The SPARK That Ignited a New Era of
Research
Claude Lenfant, M.D.
(Published in the July 9, 2002, issue
of the journal Circulation)
In the Spring of 1998, as members of both the House
and Senate were signaling their interest in increasing NIH appropriations
substantially over the next several years, the National Heart, Lung, and Blood
Institute (NHLBI) convened the "SPARK Working Group," a panel of prominent
scientists, to identify extraordinary opportunities that should be funded with
any significant increase in Institute resources.
With that objective in mind, the SPARK group set to
work and ultimately identified four broad areas of scientific opportunity, as
well as a number of enabling approaches. The areas are (1) Functional Genomics,
(2) Gene-Gene and Gene-Environment Interactions, (3)
Tissuegenesis/Organogenesis, and (4) Immunobiology.
SPARK
Report.
As the research community is well aware, the Congress
did its part. The NHLBI has already received four substantial increases in its
budget and, if the President's current budget proposal for fiscal year 2003 is
approved by the Congress, the NIH budget will be double what it was in
1998.
The purpose of this article is to demonstrate that the
Institute, in partnership with the community it serves, did its part, as well.
Although the innovative programs developed in response to the SPARK report are
too numerous to describe in detail, a few of the major ones are highlighted
herein. They are testimony to the extraordinary vision of the SPARK
participants -- much of the focus of what they recommended and what was, in
turn, implemented was on developing resources that would enable the research of
individual investigators. Perhaps the most notable examples of this sort of
investment are to be found in the combined areas of Functional Genomics and
Gene-Gene and Gene-Environment Interactions.
Functional Genomics and Gene-Gene and
Gene-Environment Interactions. In September 2000, the largest basic science
program in NHLBI history was launched, the Programs for Genomic Applications
(PGAs). Its objectives are to link genes to biological function on a genomic
scale; to establish targeted training and education programs to disseminate
information and technologies; and to enhance the development of the
technologies, biological models, methodologies, reagents, and software that
investigators will need to obtain a better understanding of the biology and
pathobiology associated with heart, lung, and blood function and disease. One
of the main stipulations of the PGA awards is that information and reagents
developed as part of the program are to be made immediately and freely
available to the research community. Already, mouse embryonic stem cell lines
developed by one of the PGAs for identifying genes relevant to cardiovascular
and pulmonary disease are being used by investigators at other institutions to
develop specific mouse models tailored to their own research interests.
See the Programs for
Genomic Applications Web pages for additional details. As
recommended in the SPARK report, attention was also focused on areas where the
interactions of genes with other genes and of genes with environmental factors
are likely to play a role in heart, lung, and blood diseases and sleep
disorders. Of particular interest are those diseases which, although known to
be caused by defects in a single gene, produce a wide range of clinical
manifestations. One example is sickle cell disease, which can be relatively
mild in some patients but takes a devastating course in others. To increase
understanding of why this occurs, research was initiated to study the modifier
genes that interact with disease genes and are responsible for clinical
variations. Studies are currently under way focusing on the modifier genes for
several additional diseases, including cystic fibrosis, alpha-1 antitrypsin
deficiency, and congenital heart disease.
Tissuegenesis/Organogenesis. The SPARK group's
interest in research on the fundamental underpinnings of organ development
formed the basis for a significant investment in stem cell research. The result
is a rigorous research effort to study stem cell plasticity in hematopoietic
and nonhematopoietic tissue. NHLBI-supported investigators are also working to
develop preparative regimens to advance hematopoietic stem cell transplantation
for hemoglobinopathies and, with additional support from other NIH components,
to isolate and characterize stem cells in a variety of animal species.
To support the development of functional tissue
engineering while allowing investigators free rein to use their imagination and
vision, the NHLBI recently announced an initiative to encourage investigators
to explore entirely new approaches and test imaginative ideas at the frontiers
of tissue engineering and regenerative medicine. It encourages the development
of myriad technologies, tools, methods, devices, cells, biomolecules, and
biomaterials that can be used for tissue engineering. This initiative has
captured the interest of both the academic research community and the small
business community.
Immunobiology. Building upon recent advances in
immunobiology, a broad, multidisciplinary research effort is now under way to
increase fundamental understanding about the cellular and molecular components
and mechanisms and the signaling processes that regulate the immune system in
cardiovascular, pulmonary, and blood tissues and that are important in
maintaining healthy tissue as well as enabling the development of disease.
Collaboration between investigators with interest in cardiovascular, pulmonary,
or blood systems and investigators who study inflammation and immunology is an
important feature of this new effort.
Other opportunities in this area include
investigations of the role of inflammation in the pathogenesis of chronic
obstructive pulmonary disease, the immunopathogenesis of chronic graft
rejection, and the influence of infectious agents on vascular diseases.
Enabling Approaches. As SPARK participants
realized, the research envisioned would require dramatically new approaches and
access to a vast and expensive assortment of technologies, resources, and
tools. Because no one institution could develop everything its investigators
would need, collaboration would be essential. Accordingly, many of the new
NHLBI initiatives have been structured so that scientific collaboration,
including the sharing of information and resources, is a requirement.
For example, the Programs of Excellence in Gene
Therapy initiative, a major translational research program launched in
September 2000 to facilitate clinical gene therapy studies, was designed to
provide investigators with access to the specialized resources needed for the
research. It provides for six National Service Corestwo clinical-grade
vector production cores, a preclinical-grade vector production core, a cell
morphology core, a hematopoietic cell processing core, and a nonhuman primate
hematopoietic cell transplantation core. The services are presently available
to all NHLBI-supported investigators at no cost.
See the Programs of Excellence in
Gene Therapy for additional details.
New clinical research networks have now been
established in pediatric heart disease, pediatric asthma, thalassemia, and
blood and marrow transplantation, and a transfusion medicine/hemostasis
clinical research network is also being formed. Seen by SPARK participants as
critical to facilitating effective clinical studies, the network approach
enables expedited evaluation of therapies and management strategies, as well as
rapid dissemination of findings to the health care community. The networks
typically comprise multiple interactive clinical centers with ready access to
patients of interest and a data coordinating center.
In the basic science arena, proposals have been
solicited to establish highly interactive, multidisciplinary centers to develop
innovative proteomic technologies and apply them to biological questions
relevant to heart, lung, blood, and sleep health and disease.
The NHLBI is also participating in NIH efforts in the
following areas: development of a public Pharmacogenetics Knowledge Base;
development of methods for the phenotypic screening of mice for heart, lung,
blood, and sleep disorders; support of innovative research in biomedical
information science and technology to promote the progress of biomedical
research; and sequencing of the rat genome.
Many of the new programs were designed so that
opportunities would be provided for the research community to learn how to use
newly developed resources. For example, the PGAs provide workshops and courses
to train researchers in the use of the data and related technologies that are
developed by the PGAs. Information about this training is available on the PGA
Educational Activities Web site, accessible through the NHLBI home page.
Investigators who apply for certain types of clinical research awards are also
being offered the opportunity to request additional funds for a Clinical
Research Skills-Development Core. (See Circulation 2002:105:1751-1752.) The
Cores will support activities to help new and relatively inexperienced clinical
investigators who are participating in the research effort enhance their
research skills and thereby progress to more senior and, ultimately,
independent investigator status.
Both the Institute and the research community it
serves owe a great debt of gratitude to their colleagues on the SPARK Working
Group for providing a vision of the future of heart, lung, blood, and sleep
research, and to their representatives in Congress and the American public for
making available the resources necessary to realize that vision.
In the near future, the NHLBI will reactivate the
SPARK Working Group to consider the next phase of research opportunities. Its
deliberations, in conjunction with those of the NHLBI Board of Extramural
Advisors and the National Heart, Lung, and Blood Advisory Council, will provide
invaluable guidance about the best use of Institute resources.
|